Scienture Holdings (SCNX) Notes Payables (2013 - 2026)
Scienture Holdings' (SCNX) quarterly Notes Payables came in at $1.1 million in Q2 2026, down 44.08% year-over-year from $2.0 million in Q2 2025, and down 44.08% quarter-over-quarter from $2.0 million in Q2 2025.
Analysis
Scienture Holdings (SCNX) Notes Payables (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed Notes Payables across 14 years of filings, most recently posting $1.1 million for Q2 2026.
- In Q2 2026, Notes Payables fell 44.08% year-over-year to $1.1 million; the TTM figure through Jun 2026 stood at $1.1 million (down 44.08% YoY), while the FY2024 annual figure was $2.3 million, changed N/A from the prior year.
- Notes Payables came in at $1.1 million for Q2 2026 at Scienture Holdings, down from $2.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $5.2 million in Q3 2023 to a low of $166667.0 in Q1 2022.
- Average Notes Payables over 5 years is $1.6 million, with a median of $1.5 million recorded in 2023.
- Year-over-year, Notes Payables surged 946.0% in 2023 and tumbled 44.08% in 2026.
- Over 5 years, Notes Payables stood at $588533.0 in 2022, then soared by 788.65% to $5.2 million in 2023, then sank by 56.3% to $2.3 million in 2024, then slipped by 12.49% to $2.0 million in 2025, then plunged by 44.08% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Notes Payables figures were $1.1 million in Q2 2026, $2.0 million in Q2 2025, and $2.0 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2023 | 5.23 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Dec 31, 2022 | 588,533.00 |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 500,000.00 |
| Mar 31, 2022 | 166,667.00 |
| Jun 30, 2021 | 225,000.00 |
| Mar 31, 2021 | 225,000.00 |
| Dec 31, 2020 | 225,000.00 |
| Sep 30, 2019 | 222,552.00 |
| Dec 31, 2018 | 181,500.00 |
| Jun 30, 2018 | 181,500.00 |
| Mar 31, 2018 | 201,725.00 |
| Dec 31, 2017 | 10,587.00 |
| Sep 30, 2017 | 251,725.00 |
| Jun 30, 2017 | 244,694.00 |